Trial Profile
The effects of ethanol on the bioavailability of oxymorphone crush-resistant extended-release tablets.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 10 Jan 2012
Price :
$35
*
At a glance
- Drugs Oxymorphone (Primary)
- Indications Pain
- Focus Pharmacokinetics
- Sponsors Endo Pharmaceuticals
- 10 Jan 2012 New trial record